Global pharmaceutical and biotechnology firm Pfizer (PFE) and biopharmaceutical firm Spero Therapeutics (SPRO) have signed a regional licensing agreement for the latter’s polymyxin …
The South Korean government is in talks with Moderna (MRNA) and Pfizer (PFE) about manufacturing their COVID-19 vaccines in the country, according to …
Global pharmaceutical and biotechnology giant Pfizer (PFE) revealed that it has commenced patient dosing in its phase 3 clinical trial, TALAPRO-3, which will …
Biopharmaceutical company Halozyme Therapeutics (HALO) has entered into a global collaboration and licensing agreement with ViiV Healthcare to further the development of ultra-long-acting …
New Zealand has tentatively cleared the COVID-19 vaccine that Pfizer (PFE) developed in partnership with BioNTech (BNTX) for 12-15-year olds, according to a …
Pfizer (PFE) has received approval from the U.S.
BioNTech SE (BNTX) and its partner Pfizer (PFE) have received Conditional Marketing Authorization (CMA) in the E.U.
GlaxoSmithKline (GSK) and Vir Biotechnology’s (VIR) investigational single-dose monoclonal antibody sotrovimab (previously named VIR-7831) has been authorized for emergency use by the U.S.
Pfizer Inc. (PFE) and Myovant Sciences (MYOV) announced that they have received the U.
Pfizer (PFE) and BioNTech (BNTX) have agreed to supply 900 million doses of their COVID-19 vaccine, COMIRNATY, to the European Union. The agreement …
